MELPHALAN FLUFENAMIDE DISCONTINUED (has an active metabolite) 
| MELPHALAN FLUFENAMIDE | ATC L01AA03
ANTINEOPLASTIC A PEPTIDE CONJUGATED ALKYLATING DRUG TREATMENT OF REFRACTORY MULTIPLE MYELOMA NITROGEN MUSTARD DRUG PRODRUG | INTRAVENOUS | Tmax 0.5 HOUR VD 35 LITER Cl 692 LITER / HOUR HT 0.035 HOUR SOLUBILITY SPARSELY SOLUBLE IN AQUEOUS SOLUTIONS | DNA | Unknown - more at DrugCentral | ANSM (in French) Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |